Baird reiterates Neutral rating on IBM stock amid quantum, mainframe focus
Baird reiterated a Neutral rating on IBM (NYSE:IBM) with a $230 price target, citing quantum computing and mainframe business dynamics. IBM's stock is down 23.77% YTD, trading at a P/E ratio of 19.69. The company reported Q2 2026 earnings below expectations, with revenue at $17.16B and EPS at $2.93. IBM partnered with OpenAI for AI integration and sold its blockchain patent portfolio to Circle Internet Group.
How this was made
The 30-second read
Why it matters
The rating and partnership could provide modest upside but are unlikely to cause a sharp move.
Market read
IBM receives a fresh analyst rating and announces a strategic AI partnership, offering limited short‑term trading ideas.
What to watch
Execution risk of integrating OpenAI models and potential competition from other cloud providers.
Background
IBM's Q2 2026 results were released weeks earlier; the article adds analyst rating and a new AI partnership.
Ticker impact
Baird reiterated a Neutral rating on IBM with a $230 price target and IBM announced a partnership with OpenAI.
likely modest upside as market prices in the new AI partnership and target raise.
Rating change is modest and the partnership is strategic but not revenue‑guaranteed.
Market effects
AI and cloud services sectors may see renewed interest in enterprise AI collaborations.
U.S. tech stocks could benefit from the partnership news.
Highlights growing competition in AI services worldwide.
Counterpoint
The partnership may not translate into immediate revenue, and IBM's core mainframe business remains under pressure.
Key entities
- AnalystBaird
Equity research firm reiterating Neutral rating on IBM.
- PartnerOpenAI
AI model provider collaborating with IBM on enterprise solutions.
